ArticleHeliyon2024

Afatinib as first-line treatment for advanced lung squamous cell carcinoma harboring uncommon EGFR G719C and S768I co-mutation: A case report and literature review.

Ruoyu Deng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.